PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?

Frederic Lamoth1,2, Dimitrios P Kontoyiannis3

  • 1Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Abstract

Insights

Early detection of non-Aspergillus invasive mold infections (NAIMI) is crucial. Polymerase chain reaction (PCR) shows promise for diagnosing NAIMI in clinical samples, offering better sensitivity and speed than traditional methods.

Area of Science:

  • Medical Mycology
  • Molecular Diagnostics
  • Infectious Diseases

Background:

  • Invasive mold infections are increasingly caused by non-Aspergillus species, including Mucorales and Fusarium.
  • Conventional diagnostic methods for these infections have limitations in sensitivity and speed.
  • Early and accurate diagnosis of non-Aspergillus invasive mold infections (NAIMI) is critical for patient outcomes.

Purpose of the Study:

  • To review the performance of molecular diagnostic tools, particularly Polymerase Chain Reaction (PCR), for detecting NAIMI.
  • To highlight novel technologies and their application in diagnosing infections caused by non-Aspergillus molds.
  • To assess the potential of PCR as a primary diagnostic method for NAIMI.

Main Methods:

  • Literature review focusing on PCR-based diagnostic assays for NAIMI.
  • Analysis of PCR performance in detecting various non-Aspergillus fungi (Mucorales, Fusarium, Scedosporium/Lomentospora).
  • Evaluation of PCR in different clinical sample types.

Main Results:

  • PCR assays demonstrate good sensitivity and specificity for detecting NAIMI.
  • Molecular methods can identify NAIMI earlier than conventional cultures and histopathology.
  • Commercial PCR tests for Mucorales are becoming available, with ongoing development for other NAIMI pathogens.

Conclusions:

  • PCR is a highly promising approach for the early diagnosis of NAIMI.
  • Standardization of protocols and development of faster, simpler techniques are needed.
  • PCR is poised to become an essential tool for diagnosing mucormycosis and other NAIMIs.